Avid Bioservices Inc (NASDAQ:CDMO)
| 14.91 Delayed Data As of 3:59pm ET |  -0.48 / -3.12%Today’s Change | 11.30 Today|||52-Week Range 31.01 | -48.90% Year-to-Date |
Latest CDMO News | Press Releases
No recent news for Avid Bioservices Inc.
Today’s Trading
| Previous close | 15.39 |
| Today’s open | 15.11 |
| Day’s range | 14.70 - 15.18 |
| Volume | 18,223 |
| Average volume (3 months) | 594,716 |
| Market cap | $972.9M |
Data as of 3:59pm ET, 12/06/2022
Growth & Valuation
| Earnings growth (last year) | +3,542.98% |
| Earnings growth (this year) | -69.09% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +24.75% |
| P/E ratio | 8.5 |
| Price/Sales | 7.93 |
| Price/Book | 5.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | +0.19 | +0.58% |
| REPLReplimune Group Inc | -1.11 | -5.56% |
| RGNXRegenxbio Inc | -0.51 | -2.21% |
| DCPHDeciphera Pharmaceut... | +0.06 | +0.40% |
Data as of 4:00pm ET, 12/06/2022
Financials
| Next reporting date | December 7, 2022 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $119.6M |
| Annual profit (last year) | $127.7M |
| Net profit margin | 106.75% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tustin, California |
Forecasts
